|
|
|
|
|||||
|
|
|
| Latest Insider Trading | Top Insider Trading Recent Week | Top 10% Owner Trading Recent Week | Filter
|
| Ticker | Owner | Relationship | Date | Transaction | Cost  |
#Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| AXGN | Scopelianos Angelo | Chief R&D Officer | Mar 16 '24 | Option Exercise | 0.00 | 25,406 | 0 | 58,250 | Mar 25 09:37 PM |
| AXGN | Scopelianos Angelo | Chief R&D Officer | Mar 21 '24 | Option Exercise | 0.00 | 2,500 | 0 | 58,604 | Mar 25 09:37 PM |
| AXGN | Scopelianos Angelo | Chief R&D Officer | Mar 21 '24 | Sale | 7.68 | 6,881 | 52,846 | 52,999 | Mar 25 09:37 PM |
| AXGN | Scopelianos Angelo | Chief R&D Officer | Mar 16 '23 | Option Exercise | 0.00 | 13,750 | 0 | 39,708 | Mar 20 06:27 PM |
| AXGN | Scopelianos Angelo | Chief R&D Officer | Dec 27 '22 | Option Exercise | 0.00 | 1,150 | 0 | 26,244 | Dec 29 08:40 PM |
| AXGN | Scopelianos Angelo | Chief R&D Officer | Mar 16 '22 | Option Exercise | 0.00 | 11,000 | 0 | 22,950 | Mar 18 04:11 PM |
| AXGN | Scopelianos Angelo | Chief R&D Officer | Dec 27 '21 | Option Exercise | 0.00 | 1,150 | 0 | 11,270 | Dec 29 04:31 PM |
| AXGN | Scopelianos Angelo | VP Research & Development | Dec 29 '20 | Sale | 17.81 | 567 | 10,098 | 5,529 | Dec 30 11:55 AM |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite